![](/fileadmin/_processed_/1/c/csm_Bild_5_Claussen_Simon_Stiftung_8a3ea85283.jpg)
![](/fileadmin/_processed_/1/c/csm_Bild_5_Claussen_Simon_Stiftung_8a3ea85283.jpg)
![](/fileadmin/einrichtung/agag/migriert/Bild_8_DGfN.jpg)
![](/fileadmin/_processed_/8/e/csm_Bild_6_DFG_eac452e6fe.jpg)
![](/fileadmin/_processed_/6/e/csm_Bild_7_Else_Kroener_Fresenius_Stiftung_9b66bd24e0.jpg)
![](/fileadmin/einrichtung/agag/migriert/Bild_9_medizinische_fakultaet.png)
Innovative Medizinische Forschung (IMF – MFM): “Diabetes and Angiogenesis: different responses to endothelin-1 (ET-1) and vascular endothelial growth factor (VEGF) and the role of hemeoxygenase-1 (HO-1)” (GS Di Marco, 2009)
Innovative Medizinische Forschung (IMF – MFM): “Anti-angiogenic effects of Angiotensinogen” (M Brand, 2007)